Alliance Pharma Share Discussion Threads

[blackhorse23] 03/4/2024 12:02

Keep buying , last chance for you below 40p

[blackhorse23] 03/4/2024 09:13

Keep buying , next week double time

[tomzimerman] 03/4/2024 07:54

You must be due a TR1 here unless your buying 1 share at a time ha ha SUPERDRY - Post 5208 SDRY Superdry Plc Blackhorse23 02 Apr 2024 11:25 1 2Sold at loss & money moving to APH

[tomzimerman] 03/4/2024 07:50

Desperate Westminster Group PLC - Post 1825 WSG Westminster Group Plc Blackhorse23 02 Apr 2024 22:21 1Another company on the way to bankrupt , money moving to APH

[blackhorse23] 02/4/2024 20:44

https://uk.citywire.com/investment_trust_insider/share-prices-and-performance/share-factsheet.aspx?InstrumentID=164220&utm_medium=website&utm_source=citywire_it_insider&utm_campaign=article-related-share

[tomzimerman] 02/4/2024 20:38

Bought more 🤣🤣🤣 Again?

[the imperialist] 02/4/2024 17:16

You still have to break into the 20s before going higher. That’s how markets work.

Buy order set for 19p.

[buoycat] 02/4/2024 15:48

This 'dip' so far lasted about a year. And that's after the previous dip.

[blackhorse23] 02/4/2024 09:44

Bought some at this dip

[blackhorse23] 02/4/2024 09:21

https://www.londonstockexchange.com/news-article/APH/full-year-trading-update/16307097

[blackhorse23] 02/4/2024 09:21

Filtered all psychopath lol

[tomzimerman] 02/4/2024 08:41

Morning desperation spam 2 April Anglo American - Global Mining Group - Post 1188 AAL Anglo American Plc Blackhorse23 02 Apr 2024 08:40Bought APH todayGattaca - It's in the DNA - Post 21 GATC Gattaca Plc Blackhorse23 02 Apr 2024 08:37Yes I did lolBELLUSCURA - Enrichment through oxygen concentrators - Post 615 BELL Belluscura Plc Blackhorse23 02 Apr 2024 08:21Money moving to APH [LSE] , excellent profitable healthcare companyItaconix formerly Revolymer - Post 9962 ITX Itaconix Plc Blackhorse23 02 Apr 2024 08:20 1 2Money moving to APH [LSE] , excellent profitable healthcare companyRedx Pharma PLC - Post 535 REDX Redx Pharma Plc Blackhorse23 02 Apr 2024 08:19Money moving to APH [LSE] , excellent profitable healthcare companyREACT Group : contamination/deep cleaning specialists - Post 1224 REAT React Group Plc Blackhorse23 02 Apr 2024 08:18Added APH today

[blackhorse23] 02/4/2024 08:16

P/S ratio 1.4x seeing as almost half of all Pharma companiesSteady revenue growth indicates optimistic strong future share price.

[blackhorse23] 02/4/2024 08:14

Next week double from here ! excellent results on the way. encouraging trading update few weeks ago indicating revenues up , profits up & high consumer demand

[blackhorse23] 02/4/2024 08:05

Time to BUY

[blackhorse23] 28/3/2024 09:52

https://simplywall.st/stocks/gb/pharmaceuticals-biotech/aim-aph/alliance-pharma-shares/news/not-many-are-piling-into-alliance-pharma-plc-lonaph-just-yet

[wad collector] 28/3/2024 08:32

Similar claims yesterday for Judges from him. Despite never having posted there before. It is almost as if he is pretending to be selling multiple holdings so that the gullible will follow his lead. Must be pretty desperate to spend so much time and effort on this policy.

[tomzimerman] 28/3/2024 08:13

Morning spam Avacta – Innovative and Disruptive Technologies for Global Health Markets - Post 57441 AVCT Avacta Group Plc Blackhorse23 28 Mar 2024 08:10Out from here & going to buy APH

[blackhorse23] 27/3/2024 14:25

100k block buying

[peddlers] 27/3/2024 12:12

Financial summary

The Group delivered record see-through(1) revenues in the Period of £182.7m
(FY22: £172.0m), up 6% versus the prior period and up 7% at constant exchange
rates ("CER"). Excluding sales from ScarAway and the US rights to Kelo-Cote in
Q1 23, both acquired in March 2022 (the "US Acquisition"), like-for-like
see-through revenues increased 6% CER.

Continued strong consumer demand, particularly in China, drove significant
recovery in Kelo-Cote franchise revenues in H2, leading to FY23 revenues of
£63.2m, up 29% CER (FY22: £50.0m). Nizoral revenues increased 3% CER to
£21.7m (FY22: £21.8m) whilst Amberen revenues declined 6% CER on an
underlying basis (excluding the leading discount store account that was lost
in 2022) and decreased 25% CER to £11.2m (FY22: £14.9m) on a reported basis.
With Other Consumer brands up 5% CER to £40.3m (FY22: £38.4m), total
see-through Consumer Healthcare revenues increased 11% CER to £136.4m.
Prescription Medicine revenues were stable at £46.3m (FY22: £46.8m),
reflecting a strong recovery in H2 as expected, as previously out of stock
products became available.
Cash and debt

Free cash flow in the Period rose 34% to £21.1m (FY22: £15.8m) and net debt
reduction continued, falling to £92.4m at 31 December 2023 (31 December 2022:
£102.0m). Group leverage(2) (as at 31 December 2023) is expected to be
significantly below that at 30 June 2023 (2.7x), and in-line with previous
guidance.

Outlook

Demand for the Group's brands remains strong. Alliance's clear focus on the
core Consumer Healthcare business, in addition to our well-established,
scalable platform across EMEA, APAC and the US, is expected to deliver
continued strong organic growth over the medium term. In 2024, the Board
anticipates our Consumer Healthcare revenues to continue to grow above that of
the broader Consumer Healthcare market, with stable Prescription Medicine
revenues.

In order to achieve our medium-term objectives, in 2024, the Board anticipates
increased investment in sales and marketing, both directly and through the
Group's distributors. The Company will also continue to deliver innovation in
2024 to further expand the reach of its brands. As a result, the Board
anticipates that profits in 2024 will be in-line with 2023.

[tomzimerman] 27/3/2024 11:38

Let him/her find out the hard way. how debt cripples companies

[blackhorse23] 27/3/2024 11:13

Results at 9th expected as below according to group trading update last month: record revenues up 6% to £182.7mFY profit expectations £50mContinued strong consumer demand Free cash flow up 34% to £21.1m

[blackhorse23] 27/3/2024 11:11

RR has 3 billion pounds debt but share went 500% up over earnings potential & profitability. Every company has debt & it doesn't matter if companies can effort it & earning is good

[baldrick1] 27/3/2024 09:45

I told you 92 million debts is a downer for APH

[baldrick1] 27/3/2024 08:27

A lot more debts to pay in year's to come..meanwhile share price languishes below 40p.